Docosanoid
In biochemistry, docosanoids are
Prominent docosanoids
Specialized proresolving mediator docosanoids
Potently bioactive agents of the specialized proresolving mediator class include:
- DHA-derived resolvins (Rvs) of the D series: RvD1, RvD2, RvD3, RvD4, RvD5, RvD6, AT-RvD1, AT-RvD2, AT-RvD3, AT-RvD4, AT-RvD5, and AT-RvD6.
- n-3 DPA-derived resolvins of the D series (RvD1n-3, RvD2n-3, and RvD5n-3) and the T series (RvT1, RvT2, RvT3, and RvT4).
- DHA-derived neuroprotectins, also termed protectins: PD1, PDX, 17-epi-PD1, and 10-epi-PD1.
- n-3 DPA derived protectins: PD1n-3 and PD2n-3.
- DHA-derived maresins: MaR1, MaR2, 7-epi-Mar1, Mar-L1, and Mar-L2.
- n-3 DPA-derived maresins: Mar1n-3, Mar2n-3, and Mar3n-3.
These DHA metabolites possess anti-
Neurofuran docosanoids
DHA can be converted non-enzymatically by free radical-mediated peroxidation to 8 different
Hydroxy-docosanoids
Cells metabolize DHA to 17S-hydroperoxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid (17-HpDHA) and then rapidly reduce this hydroperoxide to 17S-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid (17-HDHA) and similarly metabolize DHA to 13S-hydroperoxy-4Z,7Z,10Z,14Z,16Z,19Z-docosahexaenoic acid (13-HpDHA) and then to 13S-hydroxy-4Z,7Z,10Z,14Z,16Z,19Z-docosahexaenoic acid (13-HDHA). 17-HDHA exhibits potent in vitro as well as in vivo (animal model) anti-inflammatory activity while 17-HpDHA and to a lesser extent 17-HDHA inhibit the growth of cultured human breast cancer cells.[7][8] Other SPM docosanoids, e.g. RvD1 and RvD2, have anti-growth effects against cancer cells in animal models.[9]
Oxo-docosanoids
Cells can metabolize DHA to products that possess an oxo (i.e.